Ananda Developments Plc (AQSE: ANA), a developer of cannabinoid medicines, has secured the necessary funding to initiate a trial to test the effectiveness of its cannabidiol oil, MRX1, in treating
Ananda Developments Plc (AQSE: ANA), a developer of cannabinoid medicines, has secured the necessary funding to initiate a trial to test the effectiveness of its cannabidiol oil, MRX1, in treating
Ananda’s ambition is to be a leading provider of high-quality cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.
Ananda Developments (AQSE: ANA) is an AQUIS-listed healthcare company involved in the development of cannabinoid-based medicines with two concurrently running, third-party funded, Phase II randomised control trials (RCTs).
In the wake of the MRX Global acquisition, and what this means for the medical cannabis group
Light Science Technologies Holdings plc (AIM: LST), the controlled environment agriculture (“CEA”) technology and contract electronics manufacturing (“CEM”) group, provides an update on current trading.
FastForward Innovations Ltd, (AIM:FFWD) the listed investor focused on fast-growing and industry leading businesses, is pleased to announce that it has participated in the £2.1 million issuance of Convertible Loan
FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to note the announcement by portfolio company Little Green Pharma
FastForward Innovations Ltd, the AIM-quoted company focusing on making investments in fast-growing and industry-leading businesses, is pleased to note that Little Green Pharma Ltd (‘LGP’) has announced an additional A$2.5m
The Directors of Ananda announce the following progress regarding Ananda’s vision to become a significant participant in the emerging medicinal cannabis sector:
Prohibition Partners unlocks the potential of cannabis through data, intelligence and networking. They provide strategic solutions to an international client base of investors, operators, blue-chip companies, FMCG brands and government
London: London-based medicinal cannabis company has been approved, pending ratification from the licensing Board for a medicinal cannabis Dispensary licence in Antigua and Barbuda.